CIAM
BLTE

Caitong International Asset Management’s Belite Bio BLTE Stock Holding History

Caitong International Asset Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.6K Sell
349
-200
-36% -$33.6K 0.01% 749
2025
Q4 		$87.8K Buy
549
+548
+54,800% +$64.9K 0.02% 484
2025
Q3 		$74 Sell
1
-125
-99% -$8.21K ﹤0.01% 1778
2025
Q2 		$7.27K Buy
126
+77
+157% +$4.7K 0.01% 852
2025
Q1 		$3.25K Buy
+49
New +$2.95K ﹤0.01% 1156

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caitong International Asset Management's BLTE Position: Q1 2026 in Review

Caitong International Asset Management reduced its Belite Bio (BLTE) stake by 36% in Q1 2026, selling an estimated $33.6K and leaving 349 shares worth $55.6K. The position accounts for 0.01% of the portfolio, ranked #749.

Caitong International Asset Management first reported a position in BLTE in Q1 2025 and has held it in 5 quarters since. The position peaked at $87.8K in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Caitong International Asset Management held 349 shares of Belite Bio worth $55.6K as of Q1 2026.
  • Caitong International Asset Management sold 200 Belite Bio shares in Q1 2026, an estimated $33.6K.
  • Belite Bio made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #749 holding.
  • Caitong International Asset Management first reported a position in Belite Bio in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Belite Bio position peaked at $87.8K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.